R Taylor Ripley

4PUBLICATIONS
38CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 04, 2025
Co-Targeting BCL-xL with MCL-1 Induces Lethal Mitochondrial Dysfunction in Diffuse Mesothelioma.

Yuan Xu, Cristian G Medina, Deborah R Surman

|Aug 14, 2025
Co-Targeting BCL-xL with MCL-1 Induces Lethal Mitochondrial Dysfunction in Diffuse Mesothelioma.

Yuan Xu, Cristian G Medina, Deborah R Surman

|Apr 10, 2025
Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma.

Hee-Jin Jang, Meera Patel, Daniel Y Wang

|Dec 05, 2022
A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma.

Hyun-Sung Lee, Hee-Jin Jang, Maheshwari Ramineni

Pageof 1